NanoLogix expands board

Jan. 5, 2006 – NanoLogix Inc., a Sharon, Pa., nanobiotechnology company working to develop technologies for a variety of markets, announced that it has named David Rivers to its board.

Rivers was with Pfizer for 34 years and was vice president in charge of the research, development and engineering operations for the Schick & Wilkinson Sword Group since 1993, where he was responsible for new product and process activity.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.